Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED)

v3.24.0.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2021   1,569,943    
Balance, amount at Dec. 31, 2021 $ 6,042,209 $ 1,570 $ 113,099,876 $ (107,059,237)
Employee and director equity-based compensation 2,692,462 0 2,692,462 0
Net loss for the twelve months ended December 31, 2022 (8,745,293) $ 0 0 (8,745,293)
Balance, shares at Dec. 31, 2022   1,569,943    
Balance, amount at Dec. 31, 2022 (10,622) $ 1,570 115,792,338 (115,804,530)
Employee and director equity-based compensation 867,359 0 867,359 0
Net loss for the twelve months ended December 31, 2022 (7,777,184) $ 0 0 (7,777,184)
Private offering issuance of stock and warrants, net of issuance costs, shares   171,666    
Private offering issuance of stock and warrants, net of issuance costs, amount 3,634,963 $ 172 3,634,791 0
Debt discount for related party loan warrants 439,594 $ 0 439,594 0
Fractional Shares from Split, shares   (290)    
Fractional Shares from Split, amount 0      
Common stock issued on prefunded warrant exercise, shares   78,021    
Common stock issued on prefunded warrant exercise, amount 47 $ 78 (31) 0
Private sales of common stock - other, shares   125,324    
Private sales of common stock - other, amount 155,000 $ 125 154,875 0
Private sales of common stock - related party, shares   437,692    
Private sales of common stock - related party, amount 485,000 $ 438 484,562 0
Balance, shares at Dec. 31, 2023   2,382,356    
Balance, amount at Dec. 31, 2023 $ (2,205,843) $ 2,383 $ 121,373,488 $ (123,581,714)